| Lactose (India) Ltd | 145 Cr. | 115 | 237/84.3 | 32.1 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.38 Cr. | 1.77 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,256 Cr. | 391 | 479/192 | 88.1 | 24.3 | 0.17 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.2 Cr. | 43.4 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 45.1 Cr. | 30.8 | 31.0/17.0 | 107 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 53.9 Cr. | 71.5 | 124/69.7 | 14.6 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 56,034 Cr. | 1,986 | 2,286/1,275 | 22.3 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 314 Cr. | 12.9 | 19.0/10.8 | 18.9 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 18.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 784 Cr. | 1,660 | 1,999/635 | 27.1 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 98.4 Cr. | 19.7 | 32.0/17.0 | 26.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,033 Cr. | 351 | 449/219 | 9.23 | 133 | 0.71 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 5.67 Cr. | 27.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.15 Cr. | 2.87 | 8.45/2.11 | 4.06 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 458 Cr. | 471 | 499/211 | 69.2 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,358 Cr. | 1,002 | 1,565/978 | 39.4 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 53.2 Cr. | 0.26 | 1.12/0.25 | 3.50 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 36.5 Cr. | 13.9 | 26.3/7.10 | 17.8 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.58 Cr. | 9.49 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 163 Cr. | 457 | 859/431 | 9.24 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 87.9 Cr. | 87.9 | 92.5/26.1 | 166 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,234 Cr. | 1,361 | 2,452/1,334 | 44.3 | 174 | 0.79 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 22.5 Cr. | 49.1 | 88.7/36.1 | 48.8 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.0 Cr. | 5.20 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 19.3 Cr. | 129 | 152/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 57.5 Cr. | 105 | 114/9.41 | 39.7 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.3 Cr. | 41.5 | 80.0/33.0 | 50.5 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.15 Cr. | 20.5 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,509 Cr. | 548 | 1,028/514 | 27.0 | 72.4 | 0.22 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 81.8 Cr. | 18.9 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.5 Cr. | 22.7 | 43.7/17.4 | 50.0 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 88,390 Cr. | 2,141 | 3,055/2,115 | 53.0 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 228 Cr. | 395 | 524/241 | 23.3 | 123 | 1.14 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 55.9 Cr. | 39.0 | 62.6/26.7 | 87.3 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 68,900 Cr. | 1,186 | 1,365/994 | 20.1 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 161 Cr. | 259 | 303/159 | 154 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 798 Cr. | 79.6 | 123/74.0 | 20.6 | 32.6 | 1.88 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 42.7 Cr. | 32.7 | 49.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,334 Cr. | 1,629 | 1,902/919 | 59.5 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.38/0.55 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 225 Cr. | 29.4 | 65.0/26.0 | 14.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 4.67 Cr. | 7.98 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.60 | 6.57/2.82 | 307 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 59,256 Cr. | 27,885 | 37,000/25,260 | 39.3 | 1,888 | 1.70 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,865 Cr. | 757 | 972/550 | 28.6 | 226 | 0.66 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 185 Cr. | 65.3 | 100/31.3 | 51.8 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,211 Cr. | 1,687 | 1,740/740 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,790 Cr. | 1,341 | 1,870/1,110 | 397 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 837 Cr. | 240 | 330/154 | 19.5 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,048 Cr. | 784 | 840/270 | 16.5 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,270 Cr. | 464 | 808/432 | 22.4 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,485 Cr. | 1,051 | 1,595/991 | 21.0 | 768 | 0.95 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,28,015 Cr. | 3,783 | 3,882/2,886 | 59.1 | 250 | 0.85 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 966 Cr. | 105 | 284/98.0 | | 41.3 | 0.48 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,411 Cr. | 15.0 | 23.5/14.1 | 22.5 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,288 Cr. | 530 | 1,328/521 | 59.1 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,028 Cr. | 177 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,31,184 Cr. | 1,797 | 1,910/1,547 | 37.4 | 324 | 0.89 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,626 Cr. | 593 | 744/441 | 410 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,034 Cr. | 324 | 335/175 | 37.4 | 81.2 | 0.12 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,332 Cr. | 324 | 502/265 | 40.9 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,354 Cr. | 211 | 260/111 | 124 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,667 Cr. | 4,198 | 6,718/4,146 | 26.2 | 340 | 2.79 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,921 Cr. | 2,370 | 2,725/1,772 | 35.2 | 335 | 0.84 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,404 Cr. | 5,666 | 6,739/4,904 | 30.6 | 373 | 2.21 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 176 Cr. | 50.0 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,951 Cr. | 5,017 | 5,993/3,701 | 32.5 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 125 Cr. | 101 | 224/81.0 | 12.9 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,188 Cr. | 357 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,168 Cr. | 822 | 1,998/604 | 79.8 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 21,091 Cr. | 16,439 | 19,748/10,060 | 108 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 471 Cr. | 21.0 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,213 Cr. | 905 | 1,490/660 | 10.5 | 483 | 0.66 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,274 Cr. | 41.5 | 87.7/40.0 | 30.1 | 21.8 | 0.48 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,638 Cr. | 191 | 332/162 | 24.6 | 59.3 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 40.0 Cr. | 25.3 | 130/23.6 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 275 Cr. | 77.1 | 167/72.2 | 135 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 95,590 Cr. | 2,093 | 2,403/1,774 | 22.1 | 430 | 0.57 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 970 Cr. | 484 | 945/464 | 12.1 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,250 Cr. | 1,005 | 1,040/501 | 79.4 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 980 Cr. | 944 | 1,235/596 | 20.0 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 152 Cr. | 70.3 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 635 Cr. | 132 | 227/123 | 36.1 | 104 | 2.28 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 586 Cr. | 335 | 500/265 | 21.2 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,298 Cr. | 1,086 | 1,250/802 | 34.8 | 414 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,075 Cr. | 1,792 | 1,952/1,303 | 39.1 | 243 | 0.86 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,335 Cr. | 200 | 302/193 | 30.5 | 38.0 | 1.25 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,538 Cr. | 1,440 | 1,758/1,168 | 36.9 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,421 Cr. | 82.5 | 127/57.5 | 20.8 | 59.7 | 0.97 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 777 Cr. | 95.2 | 124/67.2 | 26.2 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,263 Cr. | 245 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,984 Cr. | 242 | 457/217 | 295 | 96.9 | 0.56 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,355 Cr. | 1,593 | 2,496/1,243 | 30.9 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,542 Cr. | 353 | 498/285 | 65.2 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,930 Cr. | 574 | 621/412 | 27.3 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 55,287 Cr. | 1,959 | 2,286/1,275 | 22.0 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,800 Cr. | 2,586 | 3,516/1,921 | 46.0 | 101 | 1.62 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,424 Cr. | 1,664 | 2,131/1,200 | 23.8 | 610 | 1.08 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,852 Cr. | 421 | 528/359 | 30.4 | 149 | 1.20 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,222 Cr. | 1,558 | 1,910/1,097 | 51.0 | 227 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,06,749 Cr. | 1,279 | 1,406/1,020 | 18.5 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,614 Cr. | 230 | 322/178 | 24.2 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,166 Cr. | 1,500 | 1,673/1,310 | 22.3 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,685 Cr. | 1,932 | 2,641/1,551 | 24.9 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 295 Cr. | 100 | 203/93.5 | 21.1 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,521 Cr. | 144 | 191/105 | 13.9 | 107 | 0.35 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 54.9 Cr. | 33.8 | 67.7/32.6 | 19.3 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 51,366 Cr. | 384 | 425/291 | 108 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,625 Cr. | 1,610 | 2,050/1,430 | 35.9 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 114 Cr. | 71.5 | 132/70.0 | 16.7 | 49.2 | 1.67 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 346 Cr. | 146 | 205/67.8 | 32.7 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,565 Cr. | 9,026 | 10,691/6,301 | 97.6 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,966 Cr. | 680 | 843/544 | 34.7 | 118 | 0.68 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 164 Cr. | 78.2 | 137/75.2 | 8.75 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,739 Cr. | 5,665 | 5,868/4,492 | 28.8 | 1,116 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,658 Cr. | 847 | 1,124/725 | 26.2 | 271 | 1.26 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 427 Cr. | 748 | 1,449/740 | | 690 | 0.65 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 32,472 Cr. | 2,599 | 3,116/2,022 | 33.4 | 345 | 1.06 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,419 Cr. | 305 | 392/258 | 23.2 | 133 | 1.74 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,532 Cr. | 387 | 575/312 | 18.5 | 147 | 0.25 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,392.09 Cr | 1,155.19 | | 52.60 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |